Empagliflozin Prescribing at BALSALL COMMON & MERIDEN GROUP PRACTICE
Drugs used in diabetes | Endocrine System
Items (12m)
1,939
Total Quantity
57.7K
NHS Cost
£71.6K
vs National Avg
+209.8%
BALSALL COMMON & MERIDEN GROUP PRACTICE prescribed 1,939 items of Empagliflozin over the last 12 months at a cost of £71,627 to the NHS. This is 209.8% above the national average prescribing rate. Empagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
146
Jul 2026
127
Jul 2026
150
Jul 2026
140
Jul 2026
161
Jul 2026
169
Jul 2026
152
Jul 2026
166
Jul 2026
164
Jul 2026
199
Jul 2026
177
Jul 2026
188
Prescribing Details
| Total Items | 1,939 |
|---|---|
| Total Quantity | 57,669 |
| Total NHS Cost | £71,627 |
| Presentations | 2 different forms |
| vs National Average | +209.8% |
Empagliflozin Prescribing Comparison
| This practice | 1,939 items |
|---|---|
| National average per practice | 626 items |
| Difference | +209.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.